Pfizer
PFE
$23.97
Share price
0.38%
Change (1 day)
-13.59%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Total assets
Total assets on the balance sheet as of March 2025 : $208.02 Billion USD
According to Pfizer's latest financial reports the company's total assets are $208.02 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Pfizer - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $213.39 B | -5.79% |
| 2023-12-31 | $226.50 B | 14.86% |
| 2022-12-31 | $197.20 B | 8.67% |
| 2021-12-31 | $181.47 B | 17.67% |
| 2020-12-31 | $154.22 B | -7.97% |
| 2019-12-31 | $167.59 B | 5.13% |
| 2018-12-31 | $159.42 B | -7.2% |
| 2017-12-31 | $171.79 B | 0.11% |
| 2016-12-31 | $171.61 B | 2.53% |
| 2015-12-31 | $167.38 B | -0.11% |
| 2014-12-31 | $167.56 B | -2.64% |
| 2013-12-31 | $172.10 B | -7.37% |
| 2012-12-31 | $185.79 B | -1.17% |
| 2011-12-31 | $188.00 B | -3.6% |
| 2010-12-31 | $195.01 B | -8.42% |
| 2009-12-31 | $212.94 B | 91.59% |
| 2008-12-31 | $111.14 B | -3.57% |
| 2007-12-31 | $115.26 B | -0.24% |
| 2006-12-31 | $115.54 B | -1.22% |
| 2005-12-31 | $116.97 B | -4.96% |
| 2004-12-31 | $123.07 B | 5.4% |
| 2003-12-31 | $116.77 B | 151.91% |
| 2002-12-31 | $46.35 B | 18.4% |
| 2001-12-31 | $39.15 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $115.12 B | -44.66% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $193.67 B | -6.90% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $92.42 B | -55.57% | 🇺🇸 USA |
 Eli Lilly LLY | $89.38 B | -57.03% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | -51.96% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $78.54 B | -62.24% | 🇬🇧 UK |
 Amgen AMGN | $89.36 B | -57.04% | 🇺🇸 USA |
 Abbott Laboratories ABT | $81.44 B | -60.85% | 🇺🇸 USA |
 AstraZeneca AZN | $106.25 B | -48.92% | 🇬🇧 UK |